Hospitals and health systems engaged in clinical trials enjoy several benefits — the ability to provide the latest treatment options to patients, the prestige of being a research organization, as well ...
Together, the panelists discussed the multifaceted challenges that rural communities face in accessing clinical trials and offered actionable strategies to overcome these barriers. Breaking Down ...
A cancer diagnosis presents patients with complex treatment decisions. While traditional therapies like surgery, chemotherapy, and radiation remain standard options, clinical trials offer additional ...
Among the many catchphrases of the Affordable Care Act individual mandates, pre-existing conditions clinical trials is one that has flown under the radar. But in terms of immediate impact, it is one ...
Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly ...
In this interview, News Medical speaks with the Healthcare Business of LexisNexis® Risk Solutions about optimizing clinical trial screening and digital health programs through a better understanding ...
In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
Clinical trials are the engine of modern cancer care, transforming scientific discoveries into new treatments that can save ...
Key market opportunities lie in adopting leading metrics and KPIs for predictive project management in clinical research. By utilizing tools like Earned Value Management (EVM), organizations can ...
Different groups of people—men, women, children, and people of different races or ethnic backgrounds—respond differently to different drugs. Clinical trials are supposed to drive advances in medicine ...
Matthew Leets, head of global trade compliance at Alkermes, discusses the complexities of shipping investigational products in global trials.